ProKidney Stock Analysis

PROK
 Stock
  

USD 8.80  0.31  3.40%   

The recent indifference towards the small price fluctuations of ProKidney Corp may encourage traders to take a closer look at the company as it is trading at a share price of 8.80 on 12,141 in trading volume. The company executives did not add any value to ProKidney Corp investors in November. However, most investors can still diversify their portfolios with ProKidney Corp to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.35. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the ProKidney Corp partners.
Please check Your Equity Center.
  
The ProKidney Corp stock analysis report makes it easy to digest most publicly released information about ProKidney Corp and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ProKidney Stock analysis module also helps to analyze the ProKidney Corp price relationship with some important fundamental indicators such as market cap and management efficiency.

ProKidney Stock Analysis Notes

About 43.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.21. ProKidney Corp had not issued any dividends in recent years. The entity had 1:1 split on the 12th of July 2022. ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina. Prokidney Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people. To find out more about ProKidney Corp contact Dr DVM at 336 999 7028 or learn more at https://www.prokidney.com.

ProKidney Corp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ProKidney Corp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ProKidney Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ProKidney Corp has very high historical volatility over the last 90 days
The company currently holds 36.99 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist ProKidney Corp until it has trouble settling it off, either with new capital or with free cash flow. So, ProKidney Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ProKidney Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ProKidney to invest in growth at high rates of return. When we think about ProKidney Corp's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (55.15 M) with profit before overhead, payroll, taxes, and interest of 0.
ProKidney Corp currently holds about 21.88 M in cash with (50.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Roughly 43.0% of ProKidney Corp outstanding shares are owned by corporate insiders

ProKidney Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 3.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ProKidney Corp's market, we take the total number of its shares issued and multiply it by ProKidney Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (0.3088) % which means that it has lost $0.3088 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.5169) %, meaning that it created substantial loss on money invested by shareholders. ProKidney Corp management efficiency ratios could be used to measure how well prokidney corp manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of December, ProKidney Corp holds the Coefficient Of Variation of 1401.08, risk adjusted performance of 0.114, and Semi Deviation of 6.98. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProKidney Corp, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for ProKidney Corp, which can be compared to its competitors. Please check ProKidney Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if ProKidney Corp is priced some-what accurately, providing market reflects its current price of 8.8 per share. Given that ProKidney Corp has jensen alpha of 0.3724, we recommend you to check out ProKidney Corp's recent market performance to make sure the company can sustain itself at a future point.

ProKidney Corp Price Movement Analysis

The output start index for this execution was three with a total number of output elements of fifty-eight. ProKidney Corp Triple Exponential Moving Average indicator shows smoothing effect of ProKidney Corp price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
.

ProKidney Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProKidney Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProKidney Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ProKidney Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ProKidney Corp Predictive Daily Indicators

ProKidney Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ProKidney Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ProKidney Corp Forecast Models

ProKidney Corp time-series forecasting models is one of many ProKidney Corp's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ProKidney Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About ProKidney Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ProKidney Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ProKidney shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as ProKidney Corp. By using and applying ProKidney Stock analysis, traders can create a robust methodology for identifying ProKidney entry and exit points for their positions.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina. Prokidney Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ProKidney Corp to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module
Please check Your Equity Center. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for analysis

When running ProKidney Corp price analysis, check to measure ProKidney Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProKidney Corp is operating at the current time. Most of ProKidney Corp's value examination focuses on studying past and present price action to predict the probability of ProKidney Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ProKidney Corp's price. Additionally, you may evaluate how the addition of ProKidney Corp to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is ProKidney Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.6 B
Return On Assets
(0.31) 
Return On Equity
(0.52) 
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine ProKidney Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.